Published 2022
Table of Contents:
“…Interpreting the flexibilities under the TRIPS agreement -- Intellectual Property Exhaustion and Parallel Imports of Pharmaceuticals: A Comparative and Critical Review -- Compulsory license and government use -- Access to genome editing technologies -- Bolar exception -- Patent oppositions in India -- Protection of clinical test data -- Courts and Pharmaceutical Patents -- Robust
Patent Examination or Deep Harmonization? Cooperation and Work Sharing between Patent Offices -- IPRs, Competition Law and excessive pricing of medicines -- The impact of TRIPS plus rules -- Patent Linkages and its Impact on Access to Medicines.…”
Link to Metadata
Electronic
eBook